India's Zydus Cadila to make Gilead's potential COVID-19 drug remdesivir

India's Zydus Cadila to make Gilead's potential COVID-19 drug remdesivir Zydus, listed as Cadila Healthcare, joins other Indian pharmaceutical companies Cipla Ltd, Jubilant Sciences Ltd and privately held Hetero Labs Ltd in signing non-exclusive pacts with Gilead for the drug. https://ift.tt/eA8V8J